About 7 results found for searched term "60-35-5" (0.146 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5662 | Folinic acid calcium salt pentahydrate | Antifolate |
| Leucovorin calcium salt pentahydrate | ||
| Folinic Acid pentahydrate is a reduced form of Folinic Acid that can be used in combination with other chemotherapy-like compounds. *The compound is unstable in solutions, freshly prepared is recommended | ||
| M30350 | E6201 | MEK |
| ER-806201 | ||
| E6201 (ER-806201) is an ATP-competitive dual kinase inhibitor of MEK1 and FLT3. E6201 inhibits MEK1- induced ERK2 phosphorylation with an IC50 value of 5.2 nM, MKK4-induced JNK phosphorylation with an IC50 value of 91 nM, and MKK6-induced p38 MAPK phosphorylation with an IC50 value of 19 nM. Anti-tumor and anti-psoriasis efficacy. | ||
| M42419 | α-Glucosidase-IN-24 | Glucosidase |
| α-Glucosidase-IN-24 is an α-Glucosidase inhibitor with an IC50 of 451 μM. | ||
| M44762 | Acetamide | Others |
| Acetamide is used as an intermediate in the synthesis of methylamine, thioacetamide, and insecticides, and as a plasticizer in leather, cloth and coatings. Acetamide has carcinogenicity. | ||
| M29434 | BAY-6035 | Histone Methyltransferase |
| BAY-6035 is a potent, selective and substrate-competitive inhibitor of SMYD3. BAY-6035 inhibits methylation of MEKK2 peptide with an IC50 of 88 nM. | ||
| M30365 | AS604872 | Prostaglandin Receptor |
| AS604872 is an orally active, potent and selective prostaglandin F2α receptor (FP) antagonist with a Ki of 35 nM in humans, 158 nM in rats and 323 nM in mice. AS604872 inhibits contractions and delays labour. | ||
| M30999 | BPH-1358 mesylate | Antibiotic |
| NSC50460 mesylate | ||
| BPH-1358 mesylate (NSC50460 mesylate) is a potent human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS) inhibitor with IC50s of 1.8 μM and 110 nM, respectively. BPH-1358 mesylate is active against S. aureus in vitro (MIC ~250 ng/mL). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
